ArticleCancer research communications2023

Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors.

Brian J Francica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.